Dr. Jayanthi Srinivasiah, MD

Dr. Srinivasiah practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Srinivasiah's NPI, 1437137015, was assigned on January 4, 2006. Dr. Srinivasiah holds Georgia license 033204.

Dr. Srinivasiah's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Srinivasiah's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Srinivasiah is also affiliated with Northside Hospital Forsyth. The medical group on file is Northside Hospital Cancer Institute. Dmand AI also links Dr. Srinivasiah to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srinivasiah practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Srinivasiah's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Srinivasiah is licensed in Georgia.

CMS data shows 1,299 Medicare services from Dr. Srinivasiah across 4 procedure codes in 2024, all of them office visits, for 356 Medicare patients. Medicare paid $61,574 for them. Every service was in an office.

CMS counts 356 Medicare patients who saw Dr. Srinivasiah in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Srinivasiah's median patient age at 70, with 77% women.

In 2024, Dr. Srinivasiah wrote 5,792 Medicare Part D claims for 529 patients. 86% of them were for generic drugs. CMS names the drug for 5,236 of them, across 94 drugs with 11 or more claims each, at $3,612,636 in total drug cost. In 2023, CMS named 5,180 claims across 94 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Srinivasiah for performance year 2024, reported individually. Dr. Srinivasiah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Srinivasiah as offering telehealth.

CMS Open Payments shows 78 general payments to Dr. Srinivasiah from 30 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Gilead Sciences, Inc. paid the most, $1,643.